Concepedia

E. Kaukel

EK

Statistics

Publications

30

Citations

6.8K

H-Index

22

Active since

1972

Affiliations

LungenClinic Grosshansdorf(Current)

Allgemeines Krankenhaus Celle

Asklepios Fachkliniken München-Gauting

Universität Hamburg

Asklepios Klinikum Harburg

E. Kaukel is an author at LungenClinic Grosshansdorf specializing in medicine, oncology, and chemotherapy.

Publications per year

1972–2023

30

Publications

30

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2003 · 3.1K citations

, , +13

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Frank V. Fossella, Jose R. Pereira, Joachim von Pawel et al. · Journal of Clinical Oncology · 2003 · 943 citations

, , +15

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

U. Gatzemeier, Aleksandra Szczęsna, E. Kaukel et al. · Journal of Clinical Oncology · 2007 · 880 citations · Full text

, , +14

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

U. Gatzemeier, A Płużańska, A. Szczęsna et al. · Journal of Clinical Oncology · 2004 · 300 citations

, , +15

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2023 · 253 citations

, , +13

1–5 of 30